Knowledge, Attitude and Perception of Pregnant Women Regarding Medications

NCT06925672 | Active Not Recruiting

• 1 other identifier: FMASU MS 185/2025
• Study Type: observational
• Target: 150
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this observational study is to learn about the pregnant women's knowledge, attitude, and perception regarding the use of medications in pregnancy. The main question it aims to answer is: What is the present knowledge, attitude, and perception of pregnant women regarding medication use? Participants (pregnant women) already attending the antenatal clinic for routine follow-up will answer survey questions about their knowledge, attitude, and beliefs about medication use and restriction during pregnancy, as well as the source of their information.

Conditions

Medications in Pregnancy

Keywords

pregnancy; medication; attitude; perception; knowledge; teratogenic

Outcome Measures

Primary Outcomes (1)

• Knowledge of pregnant women regarding medication use and restriction in pregnancy.

  Degree of knowledge (information) that the pregnant women have about medication use and restriction during pregnancy, as well as the source of their information, as assessed by answering the questions in sections B and D in the questionnaire.

  Once at recruitment

Secondary Outcomes (2)

• Attitude of pregnant women regarding medication use

  Once at recruitment

• Perception and beliefs of pregnant women regarding medication use and restriction

  Once at recruitment

Study Arms (1)

Pregnant women

Pregnant women attending the Ain shams University Maternity Hospital

Other: Questionnaire

Interventions

Questionnaire OTHER

This is an anonymous questionnaire; based upon previous similar studies. The questionnaire comprises closed-ended questions categorized into four sections, along with fifth section consisting of statements pertaining to respondents' beliefs: A. Section A (10 items) will contain information about the participant's socio-demographic and health related characteristics. B. Section B (7 items) will assess their knowledge about medication use and restriction, during pregnancy. C. Section C (4 items) will assess their attitude about medication. D. Section D (4 items) will assess the source of their information. E. Section E (9 statements) will assess their beliefs about medications use during pregnancy. This questionnaire will be presented in its Arabic version.

Also known as: survey

Pregnant women

Eligibility Criteria

• Age: 18 Years - 50 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Pregnant women who attend the Ain shams University Maternity Hospital for their routine antenatal check-up visits

You may qualify if:

• Pregnant women attending the Ain shams University Maternity Hospital

You may not qualify if:

• Pregnant ladies refusing to participate in study.
• Pregnant ladies needing immediate transport to emergency department.
• Pregnant ladies needing immediate intervention.

Sponsors & Collaborators

• Rania Hassan Mostafa: lead

Study Sites (1)

Ain Shams University Maternity Hospital

Cairo, Egypt

Location

MeSH Terms

Conditions

Behavior

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Ahmed Khairy, MD

  Faculty of Medicine, Ain Shams University.

  STUDY CHAIR

• Ebtihal M Eltaieb, MD

  Faculty of Medicine, Ain Shams University.

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: April 7, 2025
• First Posted: April 13, 2025
• Study Start: May 1, 2025
• Primary Completion: October 12, 2025
• Study Completion: January 1, 2026
• Last Updated: December 8, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, ANALYTIC CODE
• Time Frame: The study protocol and the questionnaire used will be available starting (May 2025) till (May 2030) The analytic code will be available after publishing the results (expected by May 2026) for 5 years
• Access Criteria: The study protocol, the questionnaire used, and the analytic code will be made PUBLICLY available on OSF platform.

Locations

EG (1)